Atossa Therapeutics (ATOS)'s 30-day implied volatility (IV30) was 106.7% at the close on November 18, 2026, down from 108.3% the day before, against a 52-week range of 50.7% to 125.2%. Its 20-day historical volatility was 119.4%.
Data as of November 18, 2026.